we are going under $400. people have moved on and are not coming back to chipolte. it's that simple
manipulation in small biotechs is rampant. long term fundamentals will drive valuation, just need to have the stomach for it until they do. GLTA
Why would you own this stock if there are 100s of better options? So you are either short, or dumb? Also, amazing that as OMER trounced the same indexes you listed over the past few weeks you were nowhere to be found. Quit whining and get a thicker skin
Why do you keep posting here and why would you own the stock if there are so many better biotechs out there? Omer was up over the past couple of weeks much more than those indexes you listed. How come you didn't post about that?
You are either VERY short or dumb, take your pick. Also, you need to get a thicker skin
more great timing fagslurp, up 30% since you started posting. you are turning me into a millionaire!!!!
I know first hand that PKU patients are very excited about this drug. I also know, first hand, how difficult and expensive it is to be on a PKU diet. My son can literally only eat about 5 grams of protein per day, he needs special bread, pasta, etc. He didn't respond to Kuvan, as most people with classical PKU don't. This drug is a potential life changer for my son as many others. I also, do believe that many of the issues that people with PKU have as far as ADHD, mood swings, school learning are casused by high blood fee levels and I know people whose kids use Kuvan and have seen great improvement in school etc.
you are a lying sack of @#$!. My son has PKU and I know many of the people in the trial. 8% of them did not have a life threatening condition. Some of them had initial issues, but all adjusted to med. I know that MOST every person with PKU will use this drug if it comes on the market and insurance covers it. Quit with your BS and scare tactics #$%$